IQVIA分散试验deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.1With more than 90 decentralized clinical trials (DCT) underway across more than 40 countries and 30 indications, IQVIA has the experience, capabilities and reach to meet any sponsor's needs.
Nearly two-thirds of industry experts ranked IQVIA as the leader among hybrid trial solutions providers – more than any other technology or service provider.1我们经过测试的DCT模型,无与伦比的数据以及全面的技术投资组合通过扩大地理范围并提供对不同人群的访问和难以接触候选人的访问来授权试验赞助商。
IQVIA分散试验建立在全球临床运营能力和深层治疗专业知识的基础上,有助于解决一些最艰难的临床研究挑战。
1行业标准研究,2021年
在IQVIA分散试验的中心是一个专业的,高度安全的可扩展DCT平台。IQVIA分散的临床试验平台可以使所有混合和完全虚拟研究活动的编排。
Available in dozens of languages, IQVIA’s DCT platform empowers patients across the globe with a concierge digital experience, including: text reminders, alerts, live chat, 24/7 support, and a scheduling tool to confirm or reschedule study visits.
DCT并不是所有方法。每个试验环境和患者人数都有独特的需求,必须定制DCT模型以满足这些需求并确保成功。
Our Decentralized Trials team leverages IQVIA’s deep therapeutic expertise, purpose-built technology, global investigator network and unparalleled data to tailor a fully remote or hybrid solution that meets your needs.
With experience delivering decentralized trials across the North America, Latin America, Europe and Asia-Pacific, IQVIA helps sponsors of all sizes accelerate timelines and achieve study goals through:
我们很高兴在我们的标准营业时间与您交谈。
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in ourtoll-free list。